ClinicalTrials.Veeva

Menu

Antipsychotics and Metabolic Syndrome

G

Glostrup University Hospital, Copenhagen

Status

Suspended

Conditions

Metabolic Syndrome

Study type

Observational

Funder types

Other

Identifiers

NCT00636753
HC-2007-0070

Details and patient eligibility

About

The purpose of the study is to determine whether antipsychotic treatment is influence psychiatric patients due to endocrine and metabolic status and quality of life.

Enrollment

60 estimated patients

Sex

Male

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Gender male
  • Age 18-45
  • Debut drug-naive schizophrenics,
  • Caucasians
  • Consent given to take part in the project

Exclusion criteria

  • Compliance-problems
  • Major lung-/kidney/hart/lever disorders
  • Abuse of alcohol/drugs
  • Diabetes 1 and 2
  • Antihypertensive
  • Anticholesterol-reducing medication
  • Patients under duress

Trial design

60 participants in 2 patient groups

1
Description:
schizophrenic patients
2
Description:
controls

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems